Skip to main content

Oncology Precision Medicine : A Concept of Identifying Specific Genes

 The human genome comprises DNA sequences that provide a code for the synthesis and regulation of an estimated 20,000 proteins. However, there is a natural variation between individuals’ genomes that leads to differences in structure, function, and production of proteins. Precision medicine is a concept of identifying such variations in specific genes that affect the health response to interventions. Contrary to the empiric medicine method, the precision medicine approach begins with testing and analysis of the patient to pre-determine the best fit mode of treatment for the patient. Following the accomplishment of the human genome project, there had been significant progress in characterizing the human epigenome, proteome, metabolome, and pharmacogenomics that has led to the evolution of customized healthcare for the individual, especially patients suffering from cancer. 

View BIS Research Report on Oncology Precision Medicine Market


Furthermore, germline mutations and somatic mutations are critical in driving cancer imitation or progression and thus the study of structural variations via sequencing or other molecular diagnostic techniques, which have been an integral part of precision medicine and may help in the early-stage screening of the disease. Moreover, precise screening also allows targeted therapy, which has a significant role in cancer treatment as through this mode, cancer cell growth can be blocked via interfering with the targeted molecules that are involved in cancer. Further, with the global expansion of cancer incidences at such a rapid rate, there has been a demand for alternative medicine other than the traditional one. Hence, the aforementioned factors have posed a necessity for an effective treatment method that involves the precision medicine approach.


Request for free Sample: https://bisresearch.com/requestsample?id=1026&type=download


About BIS Research:

BIS Research is a global B2B market intelligence and advisory firm focusing on those emerging technological trends that are likely to disrupt the dynamics of the market.

With over 150 market research reports published annually, BIS Research focuses on high technology verticals such as 3D Printing, Advanced Materials, and Chemicals, Aerospace and Defense, Automotive, Healthcare, Electronics and Semiconductors, Robotics and UAV, and other emerging technologies.

Our in-depth market intelligence reports focus on the market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.

What distinguishes BIS Research from the rest of the players is that we don’t simply provide data but also complement it with valuable insights and actionable inputs for the success of our clients.


Comments

Post a Comment

Popular posts from this blog

Understanding How the Human Centric Lighting Market is Segmented

Lighting plays a significant role in the lives of people, it has the potential to bring about positive changes in people’s behaviour. In the year 1989, a research was carried out and it proved that natural daylight can trigger the production of melatonin and serotonin, two of the most important hormones in the human body. These two hormones are responsible for inducing peaceful sleep and happiness in people. This led to the research and development in the field of human centric lighting (HCL). According to a report published by the BIS Research , the HCL market is expected to grow at a CAGR of 37.2% and 35.2% both in terms of volume and value during the forecast period (2018 – 2024). The HCL is segmented by the component, end-user and by region. Request the Sample: Human Centric Lighting Market The human centric lighting market can be further segmented by component, type, end-users, and region. The components or the controls are further segmented as microprocessors & microco...
Post a Comment
Read more

Global Surgical Robotics Market: Analysis and Forecast, 2018-2025

Global Surgical Robotics Market: Focus on Products and Services (Surgical Systems, Instruments & Accessories, and Services & Maintenance), Applications, End Users, and Competitive Landscape: Analysis and Forecast, 2018-2025. Rising incidences of colorectal cancer, neurological disorders, interventional cardiology disorders and gynecological diseases, growing geriatric population, and active participation of the government and the industry players in the technological advancement in the field of computer assisted robotic surgeries have boosted the overall growth of this market. Another factor which significantly contributes to the revenue generation of a company is the recurring sale of equipment and accessories of a surgical system. The surgical robotics vendors generate revenue through one time sale of the surgical system and generate the recurring  revenue from the sale of equipment and accessory products and maintenance services used in the surgical system. A...
1 comment
Read more

Liquid Biopsy, North America, and Lung Cancer Occupying a Major Share in the Market

  Owing to the market availability of large number of liquid biopsy technologies, the liquid biopsy segment currently accounts for a dominating share in the global minimally invasive biopsy technologies market . However, the market growth in the segment can be attributed to the increasing demand for liquid biopsy and the strong product pipeline. For instance, CNI Second Opinion by Chronix Biomedical is presently under development and is expected to get launched during the forecast period 2019-2030. Owing to a widespread market presence of leading players and the huge prevalence of cancer, North America presently holds a major share in the global minimally invasive biopsy technologies market. According to the World Cancer Research Fund (WCRF), with an estimated 2 million cases in 2018, lung cancer is the most commonly occurring cancer in men and third-most commonly occurring cancer in women. Due to the widespread presence of cancer, the manufacturers including Biocept, Inc., Chron...
Post a Comment
Read more